CDK5R2 and Alzheimer disease: Interestingly, we noticed that CDK5R1 and CDK5R2, key promoters for NFT formation (86, 87), showed the highest expression levels in the AD group across all SL subregions, except in CA1, where their expression was highest in the PART group (Fig. 3E).